tiprankstipranks
Advertisement
Advertisement

BBIO Stock Latest News

Texas Instruments upgraded, Circle downgraded: Wall Street’s top analyst calls
The FlyTexas Instruments upgraded, Circle downgraded: Wall Street’s top analyst calls
15h ago
KR
ZS
BridgeBio initiated with an Outperform at RBC Capital
PremiumThe Fly
BridgeBio initiated with an Outperform at RBC Capital
1d ago
BBIO
BridgeBio: Advancing First-in-Class LGMD Therapy and Blockbuster ATTR Franchise Underpin Reiterated Buy and $100 Target
PremiumRatings
BridgeBio: Advancing First-in-Class LGMD Therapy and Blockbuster ATTR Franchise Underpin Reiterated Buy and $100 Target
10d ago
BBIO
BridgeBio Files NDA for LGMD2I/R9 Oral Therapy
PremiumCompany Announcements
BridgeBio Files NDA for LGMD2I/R9 Oral Therapy
10d ago
8K
BBIO
BridgeBio presents long-term efficacy, safety data from ATTRibute-CM trial
PremiumThe Fly
BridgeBio presents long-term efficacy, safety data from ATTRibute-CM trial
10d ago
BBIO
BridgeBio submits BBP-418 NDA to FDA
PremiumThe FlyBridgeBio submits BBP-418 NDA to FDA
11d ago
BBIO
BridgeBio price target raised to $106 from $91 at Mizuho
Premium
The Fly
BridgeBio price target raised to $106 from $91 at Mizuho
23d ago
BBIO
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
Premium
Ratings
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
24d ago
BBIO
BridgeBio presents Phase 3 FORTIFY interim analysis results
PremiumThe Fly
BridgeBio presents Phase 3 FORTIFY interim analysis results
29d ago
BBIO
Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
1M ago
LTH
NVO
BridgeBio initiated with an Outperform at William Blair
PremiumThe Fly
BridgeBio initiated with an Outperform at William Blair
1M ago
BBIO
JPMorgan ups BridgeBio target, adds to Analyst Focus List
PremiumThe Fly
JPMorgan ups BridgeBio target, adds to Analyst Focus List
1M ago
BBIO
BridgeBio Pharma: Advancing Late-Stage Pipeline and Near-Term Catalysts Underpin Reaffirmed Buy and $100 Target
PremiumRatingsBridgeBio Pharma: Advancing Late-Stage Pipeline and Near-Term Catalysts Underpin Reaffirmed Buy and $100 Target
1M ago
BBIO
BridgeBio Pharma Earnings Call Signals Profitable Pivot
Premium
Company Announcements
BridgeBio Pharma Earnings Call Signals Profitable Pivot
1M ago
BBIO
BridgeBio price target raised to $95 from $86 at Truist
Premium
The Fly
BridgeBio price target raised to $95 from $86 at Truist
1M ago
BBIO
BridgeBio price target raised to $98 from $96 at Morgan Stanley
PremiumThe Fly
BridgeBio price target raised to $98 from $96 at Morgan Stanley
1M ago
BBIO
BridgeBio price target raised to $125 from $100 at Evercore ISI
PremiumThe Fly
BridgeBio price target raised to $125 from $100 at Evercore ISI
1M ago
BBIO
BridgeBio price target lowered to $81 from $83 at Oppenheimer
PremiumThe Fly
BridgeBio price target lowered to $81 from $83 at Oppenheimer
1M ago
BBIO
BridgeBio Pharma: Clear Path to 2027 Profitability with Underappreciated Pipeline Upside
PremiumRatings
BridgeBio Pharma: Clear Path to 2027 Profitability with Underappreciated Pipeline Upside
1M ago
BBIO
BridgeBio: Robust Attruby Launch and Late-Stage Pipeline Support Buy Rating and Path to Sustainable Cash Generation
PremiumRatingsBridgeBio: Robust Attruby Launch and Late-Stage Pipeline Support Buy Rating and Path to Sustainable Cash Generation
1M ago
BBIO
BridgeBio reports Q4 EPS ($1.00), consensus (67c)
Premium
The Fly
BridgeBio reports Q4 EPS ($1.00), consensus (67c)
1M ago
BBIO
BridgeBio off lows as traders discuss conference appearance
Premium
The Fly
BridgeBio off lows as traders discuss conference appearance
2M ago
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >